Analysts: Walgreens Shows Long-Term Prospects and 3 Other Research Notes to Peruse

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Walgreens (NYSE:WAG): Morgan Stanley upgraded Walgreens to Overweight from Equal Weight. The firm upgraded shares based on 2016 fiscal year growth prospects when the Alliance Boots deal is completed, deal synergies, and coverage expansion. The shares’ price target is $70.


More Articles About:

To contact the reporter on this story: To contact the editor responsible for this story:

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business